FREE Registration

Learn More
FREE Register Now
8th Annual Congress of the European Society for Translational Medicine (EUSTM-2021) 20-26 September, 2021 (Virtual Congress) 8th Annual Congress of the European Society for Translational Medicine (EUSTM-2021) 20-26 September, 2021 (Virtual Congress)

Solid Tumors: Immuno-Oncology & Novel Therapeutics

If you're focusing on this Category and want to learn from the best, then check out the content we have for you.

Proudly supported by

Book My Place

Book my place

By submitting you agree to the Terms & Privacy Policy

Meet our Speakers

We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.

Hamzeh Alipour

Hamzeh Alipour

Shiraz University of Medical Sciences, Shiraz, Iran

Antonio Facchiano

Antonio Facchiano

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

Disis Mary L. (Nora)

Disis Mary L. (Nora)

Director, Cancer Vaccine Institute, University of Washington (UW), Seattle, WA, USA

David S.Hong

David S.Hong

Associate Vice President of Clinical Research, University of Texas M.D. Anderson Cancer Center

Jonathan A. Kelber

Jonathan A. Kelber

Department of Biology, California State University Northridge (CSUN), Los Angeles, California

Asseel Alregib

Asseel Alregib

School of Medicine, Taylor’s University, Subang Jaya, Malaysia

Basak Bahcivanci

Basak Bahcivanci

College of Medical & Dental Sciences, University of Birmingham, Birmingham , UK

Iris Car

Iris Car

University of Rijeka, Department of Biotechnology, Rijeka, Croatia

Bruna Corradetti

Bruna Corradetti

Houston Methodist Research Institute, Houston, USA

Silvia De Francia

Silvia De Francia

Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy

Zoran Gatalica

Zoran Gatalica

The University of Oklahoma Health Sciences Center, Oklahoma City, USA

Astero Klampatsa

Astero Klampatsa

Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, London, UK

Michael Levin

Michael Levin

Tufts University, Medford, USA.

Dario Longo

Dario Longo

Institute of Biostructures and Bioimaging (IBB), Italian National Research Council, Torino, Italy

Andreas Pircher

Andreas Pircher

Medizinische Universität Innsbruck, Innsbruck, Austria

Leana Rich M. Herrera

Leana Rich M. Herrera

Polytechnic University of the Philippines, Philippines

Che-Kai Tsao

Che-Kai Tsao

Medical Director, Ruttenberg Treatment Center, Tisch Cancer Institute, Mount Sinai Hospital, NY, USA

Qian Xie

Qian Xie

Quillen College of Medicine, East Tennessee State University, Johnson City, US

Wong Yin How

Wong Yin How

School of Medicine, Faculty of Health & Medical Sciences, Taylor's University, Subang Jaya, Malaysia

Panos Z. Anastasiadis

Panos Z. Anastasiadis

Cell Biology Program Director, Mayo Clinic Cancer Center, Jacksonville, FL, USA

Talks

Overcoming Tumor Antigen Heterogeneity in the Context of CAR T Cell therapy for Solid Tumors

20 September 2021, 09:00 AM
Astero Klampatsa

Tumor Endothelial Cells in NSCLC: headmasters of tumor immunity

20 September 2021, 10:00 AM
Andreas Pircher

Modeling Therapy-Induced Tumor Cell State Plasticity to Identify Vulnerabilities for Reducing Disease Burden

20 September 2021, 12:00 PM
Jonathan A. Kelber

Cracking open the undruggable RAS: A Clinical Perspective

20 September 2021, 02:00 PM
David S.Hong

Development of a novel biodegradable chemo-radioembolic formulation for transarterial treatment of hepatocellular carcinoma

20 September 2021, 04:00 PM
Asseel Alregib

Combination of integrated genomics with ex vivo microcancer drug screens to individualize brain cancer therapy

21 September 2021, 01:00 PM
Panos Z. Anastasiadis

Age of combination therapy in the treatment of advanced RCC: can we do it better?

21 September 2021, 02:00 PM
Che-Kai Tsao

Proteomic and N-glycome profiling of secretome from BRAFV600E mutant colon cancer cells with acquired resistance to vemurafenib

21 September 2021, 03:00 PM
Iris Car

Investigating protein- and gene-expression of 27 cytokines/chemokines in melanoma patients. Identification of a 4-genes signature

22 September 2021, 09:00 AM
Antonio Facchiano

MET as a druggable target in solid tumors

22 September 2021, 10:00 AM
Qian Xie

Flexible samarium-153 radiotherapeutic bandage for radiation therapy of skin cancer

22 September 2021, 01:00 PM
Wong Yin How

Ion channel drugs as electroceuticals for reprogramming cancer: exploiting bioelectric controls of cell and tissue function

22 September 2021, 02:00 PM
Michael Levin

Two retrospective studies on gender differences: chemotherapy toxicities in patients affected by colorectal and pancreatic cancers

23 September 2021, 10:00 AM
Silvia De Francia

Designing a Multi-Epitope Vaccine Against Cancer-Testis Antigens in Non-Small Cell Lung Cancer: an In Silico Approach

23 September 2021, 03:00 PM
Leana Rich M. Herrera

Advanced ovarian cancer: exploiting exosomes to potentiate the anti-cancer immune response

24 September 2021, 09:00 AM
Bruna Corradetti

Imaging of tumor acidosis for monitoring response to novel anticancer therapies

24 September 2021, 12:00 PM
Dario Longo

Solid Tumors: Immuno-Oncology

24 September 2021, 04:00 PM
Disis Mary L. (Nora)

Cancer therapy potential: molecular characterization of Lucilia sericata angiopoietin-1 | Poster Talk

25 September 2021, 03:00 PM
Hamzeh Alipour

Apocrine breast carcinoma from biomarkers to therapy

26 September 2021, 12:00 PM
Zoran Gatalica

Associating Transcriptomics Data with Inflammatory Markers to Understand Tumour Microenvironment in Hepatocellular Carcinoma

26 September 2021, 03:00 PM
Basak Bahcivanci